INS and type 2 diabetes mellitus: A de-sensitization of insulin signaling enhances the inflammation response and the de-sensitization observed in T2DM (Biessels et al., 2002), therefore, not only compromises growth factor signaling, and energy utilization in the brain, but also facilitates the chronic inflammation response.